Targeting the Endocannabinoid System for Neuroprotection: A 19F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA

Jianqin Zhuang; De-Ping Yang; Xiaoyu Tian; Spyros P Nikas; Rishi Sharma; Jason Jianxin Guo; Alexandros Makriyannis

Targeting the Endocannabinoid System for Neuroprotection: A ¹⁹F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA

J Pharm Pharmacol (Los Angel). 2013;1(1):002.

Authors

Jianqin Zhuang¹, De-Ping Yang², Xiaoyu Tian³, Spyros P Nikas³, Rishi Sharma³, Jason Jianxin Guo³, Alexandros Makriyannis³

Affiliations

¹ Center for Drug Discovery, Department of Pharmaceutical Sciences, and Department of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Avenue, Boston, MA 02115, USA ; Department of Chemistry, The College of Staten Island, City University of New York, 2800 Victory Boulevard, Staten Island, NY 10314, USA.
² Physics Department, College of the Holy Cross, 1 College Street, Worcester, MA 01610, USA.
³ Center for Drug Discovery, Department of Pharmaceutical Sciences, and Department of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Avenue, Boston, MA 02115, USA.

PMID: 24533425
PMCID: PMC3921897

Abstract

Fatty acid amide hydrolase (FAAH), the enzyme involved in the inactivation of the endocannabinoid anandamide (AEA), is being considered as a therapeutic target for analgesia and neuroprotection. We have developed a brain permeable FAAH inhibitor, AM5206, which has served as a valuable pharmacological tool to explore neuroprotective effects of this class of compounds. In the present work, we characterized the interactions of AM5206 with a representative AEA carrier protein, human serum albumin (HSA), using ¹⁹F nuclear magnetic resonance (NMR) spectroscopy. Our data showed that as a drug carrier, albumin can significantly enhance the solubility of AM5206 in aqueous environment. Through a series of titration and competitive binding experiments, we also identified that AM5206 primarily binds to two distinct sites within HSA. Our results may provide insight into the mechanism of HSA-AM5206 interactions. The findings should also help in the development of suitable formulations of the lipophilic AM5206 and its congeners for their effective delivery to specific target sites in the brain.

Keywords: 19F-NMR; Anandamide carrier proteins; FAAH; Human serum albumin.

Abstract

Grants and funding